Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-09

Clinical Trial Update: Nab-PTX, Ifosfamide and Cisplatin in the Treatment of Pediatric Extracranial Germ Cell Tumor. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Nab-PTX, Ifosfamide, and Cisplatin for pediatric extracranial germ cell tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)
  • IFOSFAMIDE (IFOSFAMIDE)
  • Nab-PTX (nab-paclitaxel)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Extracranial Germ Cell Tumor, Pediatric | Phase 2 | Status: UNKNOWN